Skip to main content

Table 4 Outcomes inRTRs and nonRTRs

From: COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome

 

Group

P

Transplant Pts

Non-Transplant Pts

Count (N %)

Count (N %)

Duration of hospitalization

9.83 ± 7.29, 7.50(4.00–15.00)

8.62 ± 6.63, 6.00(4.00–11.00)

0.556

Discharge status

Discharge

18 (75.0)

35 (87.5)

0.173

Expired

6 (25.0)

5 (12.5)

 

Severity

Mild

0 (0.0)

0 (0.0)

0.524

Moderate

7 (29.2)

10 (25.0)

 

Sever

8 (33.3)

11 (47.5)

 

Critical

9 (37.5)

19 (27.5)

 

ICU admission

No

15 (65.2)

27 (73.0)

0.524

Yes

8 (34.8)

10 (27.0)

 

Ventilation type

No ventilation

0 (0.0)

5 (13.2)

0.068

Nasal o2 or mask

14 (63.6)

23 (60.5)

 

NIV

2 (9.1)

6 (15.8)

 

MV

6 (27.3)

4 (10.5)

 

O2satatadmission

 

90.74 ± 8.47(93.00(88.00–96.00))

89.26 ± 6.32(90.00(85.00–95.00))

0.148

RR at admission

 

19.70 ± 3.57(20.00(18.00–20.00))

19.49 ± 2.42(19.00(18.00–20.00))

0.940

  1. Mean ± SD(MED(p25-p75))